Suppr超能文献

新冠病毒病的50多种长期影响:一项系统综述和荟萃分析

More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis.

作者信息

Lopez-Leon Sandra, Wegman-Ostrosky Talia, Perelman Carol, Sepulveda Rosalinda, Rebolledo Paulina A, Cuapio Angelica, Villapol Sonia

机构信息

Drug Development, Novartis Pharmaceuticals, New Jersey, USA.

Instituto Nacional de Cancerología, Subdirección de Investigación básica, Ciudad de México, México.

出版信息

medRxiv. 2021 Jan 30:2021.01.27.21250617. doi: 10.1101/2021.01.27.21250617.

Abstract

COVID-19, caused by SARS-CoV-2, can involve sequelae and other medical complications that last weeks to months after initial recovery, which has come to be called Long-COVID or COVID long-haulers. This systematic review and meta-analysis aims to identify studies assessing long-term effects of COVID-19 and estimates the prevalence of each symptom, sign, or laboratory parameter of patients at a post-COVID-19 stage. LitCOVID (PubMed and Medline) and Embase were searched by two independent researchers. All articles with original data for detecting long-term COVID-19 published before 1 of January 2021 and with a minimum of 100 patients were included. For effects reported in two or more studies, meta-analyses using a random-effects model were performed using the MetaXL software to estimate the pooled prevalence with 95% CI. Heterogeneity was assessed using statistics. This systematic review followed Preferred Reporting Items for Systematic Reviewers and Meta-analysis (PRISMA) guidelines, although the study protocol was not registered. A total of 18,251 publications were identified, of which 15 met the inclusion criteria. The prevalence of 55 long-term effects was estimated, 21 meta-analyses were performed, and 47,910 patients were included. The follow-up time ranged from 14 to 110 days post-viral infection. The age of the study participants ranged between 17 and 87 years. It was estimated that 80% (95% CI 65-92) of the patients that were infected with SARS-CoV-2 developed one or more long-term symptoms. The five most common symptoms were fatigue (58%), headache (44%), attention disorder (27%), hair loss (25%), and dyspnea (24%). All meta-analyses showed medium (n=2) to high heterogeneity (n=13). In order to have a better understanding, future studies need to stratify by sex, age, previous comorbidities, severity of COVID-19 (ranging from asymptomatic to severe), and duration of each symptom. From the clinical perspective, multi-disciplinary teams are crucial to developing preventive measures, rehabilitation techniques, and clinical management strategies with whole-patient perspectives designed to address long COVID-19 care.

摘要

由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的2019冠状病毒病(COVID-19)可能会出现后遗症和其他医学并发症,这些情况在初次康复后会持续数周甚至数月,这就是所谓的“长新冠”或“新冠长期症患者”。本系统评价和荟萃分析旨在识别评估COVID-19长期影响的研究,并估计处于COVID-19后阶段患者的每种症状、体征或实验室参数的患病率。两名独立研究人员检索了LitCOVID(PubMed和Medline)以及Embase数据库。纳入所有在2021年1月1日前发表的、具有检测COVID-19长期影响原始数据且至少有100名患者的文章。对于两项或更多研究中报告的影响,使用MetaXL软件采用随机效应模型进行荟萃分析,以估计合并患病率及95%置信区间。使用统计方法评估异质性。本系统评价遵循系统评价与荟萃分析的首选报告项目(PRISMA)指南,不过研究方案未进行注册。共识别出18251篇出版物,其中15篇符合纳入标准。估计了55种长期影响的患病率,进行了21项荟萃分析,纳入了47910名患者。随访时间为病毒感染后14至110天。研究参与者的年龄在17至87岁之间。据估计,感染SARS-CoV-2的患者中有80%(95%置信区间65%-92%)出现了一种或多种长期症状。最常见的五种症状为疲劳(58%)、头痛(44%)、注意力障碍(27%)、脱发(25%)和呼吸困难(24%)。所有荟萃分析均显示为中度异质性(n = 2)至高异质性(n = 13)。为了更好地理解,未来的研究需要按性别、年龄、既往合并症、COVID-19的严重程度(从无症状到重症)以及每种症状的持续时间进行分层。从临床角度来看,多学科团队对于制定预防措施、康复技术以及旨在解决长新冠护理问题的全患者视角临床管理策略至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe9d/7852236/a84fc736ddca/nihpp-2021.01.27.21250617-f0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验